http://purl.org/np/RAWIn9DX8f9Mjaky-kidQjmRfC4XM87tPVqcNN483K-o8#Head http://purl.org/np/RAWIn9DX8f9Mjaky-kidQjmRfC4XM87tPVqcNN483K-o8 http://www.nanopub.org/nschema#hasAssertion http://purl.org/np/RAWIn9DX8f9Mjaky-kidQjmRfC4XM87tPVqcNN483K-o8#assertion http://purl.org/np/RAWIn9DX8f9Mjaky-kidQjmRfC4XM87tPVqcNN483K-o8 http://www.nanopub.org/nschema#hasProvenance http://purl.org/np/RAWIn9DX8f9Mjaky-kidQjmRfC4XM87tPVqcNN483K-o8#provenance http://purl.org/np/RAWIn9DX8f9Mjaky-kidQjmRfC4XM87tPVqcNN483K-o8 http://www.nanopub.org/nschema#hasPublicationInfo http://purl.org/np/RAWIn9DX8f9Mjaky-kidQjmRfC4XM87tPVqcNN483K-o8#pubinfo http://purl.org/np/RAWIn9DX8f9Mjaky-kidQjmRfC4XM87tPVqcNN483K-o8 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://purl.org/np/RAWIn9DX8f9Mjaky-kidQjmRfC4XM87tPVqcNN483K-o8#assertion http://purl.obolibrary.org/obo/DOID_4989 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Disease http://purl.org/np/RAWIn9DX8f9Mjaky-kidQjmRfC4XM87tPVqcNN483K-o8#association http://www.w3.org/1999/02/22-rdf-syntax-ns#object http://purl.obolibrary.org/obo/DOID_4989 http://purl.org/np/RAWIn9DX8f9Mjaky-kidQjmRfC4XM87tPVqcNN483K-o8#association http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate https://w3id.org/biolink/vocab/treats http://purl.org/np/RAWIn9DX8f9Mjaky-kidQjmRfC4XM87tPVqcNN483K-o8#association http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://identifiers.org/drugbank:DB00900 http://purl.org/np/RAWIn9DX8f9Mjaky-kidQjmRfC4XM87tPVqcNN483K-o8#association http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://purl.org/np/RAWIn9DX8f9Mjaky-kidQjmRfC4XM87tPVqcNN483K-o8#association http://www.w3.org/2000/01/rdf-schema#label "Coadministration with stavudine allopurinol or ribavirin is contraindicated. ( 4 VIDEX EC is contraindicated when coadministered with the following medications: Stavudine- potential for serious and/or life-threatening events, notably pancreatitis, lactic acidosis, hepatotoxicity, and peripheral neuropathy [ see Warnings and Precautions 5.1 5.2 5.3 5.5 Allopurinol- systemic exposures of didanosine are increased, which may increase didanosine-associated toxicity [ see Clinical Pharmacology (12.3) Ribavirin- exposures of the active metabolite of didanosine (dideoxyadenosine 5'-triphosphate) are increased. Fatal hepatic failure, as well as peripheral neuropathy, pancreatitis, and symptomatic hyperlactatemia/lactic acidosis have been reported in patients receiving both didanosine and ribavirin." http://purl.org/np/RAWIn9DX8f9Mjaky-kidQjmRfC4XM87tPVqcNN483K-o8#association https://w3id.org/biolink/vocab/provided_by https://w3id.org/um/NeuroDKG http://purl.org/np/RAWIn9DX8f9Mjaky-kidQjmRfC4XM87tPVqcNN483K-o8#association https://w3id.org/biolink/vocab/relation https://schema.org/MedicalContraindication https://identifiers.org/drugbank:DB00900 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Drug http://purl.org/np/RAWIn9DX8f9Mjaky-kidQjmRfC4XM87tPVqcNN483K-o8#provenance http://purl.org/np/RAWIn9DX8f9Mjaky-kidQjmRfC4XM87tPVqcNN483K-o8#assertion http://www.w3.org/ns/prov#wasAttributedTo https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAWIn9DX8f9Mjaky-kidQjmRfC4XM87tPVqcNN483K-o8#pubinfo http://purl.org/np/RAWIn9DX8f9Mjaky-kidQjmRfC4XM87tPVqcNN483K-o8#sig http://purl.org/nanopub/x/hasAlgorithm RSA http://purl.org/np/RAWIn9DX8f9Mjaky-kidQjmRfC4XM87tPVqcNN483K-o8#sig http://purl.org/nanopub/x/hasPublicKey MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB http://purl.org/np/RAWIn9DX8f9Mjaky-kidQjmRfC4XM87tPVqcNN483K-o8#sig http://purl.org/nanopub/x/hasSignature Z0p4ng4ay2tqerdaaoCmOrIr3hqPej9UFwlEJYUQGn85yaSJuI0TYa04j3Wdd7BPnPP+E9pP8wYHkqGdXoHroUA7bATCO+hKHcBsWlMnuvo4b6VZKp75q6aH/ARlXUqZRLFvcKgEh5Q0mOXa4Pg/j96+n+m4CNltTU/tmFASl1Y= http://purl.org/np/RAWIn9DX8f9Mjaky-kidQjmRfC4XM87tPVqcNN483K-o8#sig http://purl.org/nanopub/x/hasSignatureTarget http://purl.org/np/RAWIn9DX8f9Mjaky-kidQjmRfC4XM87tPVqcNN483K-o8 http://purl.org/np/RAWIn9DX8f9Mjaky-kidQjmRfC4XM87tPVqcNN483K-o8 http://purl.org/dc/terms/created 2021-08-25T14:00:28.988+02:00 http://purl.org/np/RAWIn9DX8f9Mjaky-kidQjmRfC4XM87tPVqcNN483K-o8 http://purl.org/dc/terms/creator https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAWIn9DX8f9Mjaky-kidQjmRfC4XM87tPVqcNN483K-o8 https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM http://purl.org/np/RAWIn9DX8f9Mjaky-kidQjmRfC4XM87tPVqcNN483K-o8 https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM http://purl.org/np/RAWIn9DX8f9Mjaky-kidQjmRfC4XM87tPVqcNN483K-o8 https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate http://purl.org/np/RAhNHZw6Urw_Mccs4qy6Ws3C9CRuaHpQx8AwuApbWkqnY